Specialized Center

Senology

Introduction

Breast cancer is the most common malignancy in women. Every year in Italy, more than 55.000 new cases of breast cancer are diagnosed. Early diagnosis, supported by regular screening and a healthy lifestyle, significantly improves clinical outcomes. In its early stages, the cancer is highly curable (95-97%) with conservative and body-conserving procedures.

The clinic is part of the Intercompany Breast Unit (Multimedica – San Giuseppe – Castellanza – IGEA Nursing Home), which operates according to a Certified PDTA and guarantees a multidisciplinary and coordinated path in all phases of diagnosis and treatment.

Intercompany Breast Unit

The inter-company Breast Unit is made up of a multidisciplinary team that works closely together to ensure comprehensive care and a coordinated treatment plan.

The following work in synergy within the structure:

Breast surgeons
Reconstructive breast surgeon
Oncologists
Breast radiologists
Pathologists
Gynecologists
Geneticists

The team is available to communicate with the General practitioners, promoting continuity of care and uniformity in clinical decisions.

Diagnostic and therapeutic decisions are discussed collegially in the multidisciplinary meetings (MDM), which represent one of the cornerstones of certified Breast Units. From this discussion, personalized treatment plans are developed, tailored to the patient's specific clinical needs.

Breast Radiology

The Breast Radiology unit uses high-tech instruments for the diagnosis of breast pathology:

2D digital mammography and 3D tomosynthesis
Breast ultrasound
16-channel breast MRI
Ultrasound-guided breast biopsies
Mammographically guided breast biopsies (Tomo-Biopsy with 3D vertical stereotactic system for non-palpable lesions or microcalcifications)

These methods allow the identification of even small lesions and guarantee high diagnostic accuracy.
The latest technologies also allow for a reduction in radiation dose thanks to better centering and a smaller number of exposures required.

The results of the histological tests are communicated directly by the breast surgeon, which illustrates to the patient the clinical picture and the therapeutic proposals defined in a multidisciplinary setting.

Senology

Each intervention is planned after a careful counseling with the patient, who receives clear and complete information on the proposed procedure.

The surgical team performs targeted interventions based on the stage and type of disease.

Among the procedures performed:

Quadrantectomy
Sentinel Lymph Node Biopsy
Removal of non-palpable lesions (with magnetic system Sentimag)
Lymphadenectomy
Skin-sparing mastectomy
Mastectomy with sparing of the nipple-areola complex
Immediate reconstruction with expander or definitive prosthesis

The structure guarantees hospitalization and intervention in a short time, approximately within 15 days with the National Health Service.

Oncology

- Oncologists of the Breast Unit are responsible for planning and administering pharmacological therapies, both in the post-operative phase neoadjuvant (pre-intervention) both in the postoperative, following updated and personalized protocols for each case.

The team also manages the follow-up of breast pathology, monitoring the patient over time to ensure continuity of care and timely subsequent interventions.

Genetics

For patients who present specific clinical criteria, the Breast Unit offers the possibility of performing the research on BRCA1 and BRCA2 genetic mutations, after evaluation with the Geneticist and the oncologist. This analysis allows us to identify any hereditary predispositions and plan personalized surveillance or interventions.

Days and times:

Thursday from 08:30 am to 15:40 pm

Clinics and Contacts

Check-ups in symptomatic and asymptomatic patients, Follow-up of oncology patients, delivery of biopsy/fine needle aspiration tests, dressings, delivery of definitive histological tests.